NDC 60793-117

Cytomel

Liothyronine Sodium

Cytomel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Liothyronine Sodium.

Product ID60793-117_37473343-afef-44cb-8d39-2ed42104c865
NDC60793-117
Product TypeHuman Prescription Drug
Proprietary NameCytomel
Generic NameLiothyronine Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1956-05-08
Marketing CategoryNDA / NDA
Application NumberNDA010379
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameLIOTHYRONINE SODIUM
Active Ingredient Strength50 ug/1
Pharm Classesl-Triiodothyronine [EPC],Triiodothyronine [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 60793-117-01

100 TABLET in 1 BOTTLE (60793-117-01)
Marketing Start Date1956-05-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60793-117-01 [60793011701]

Cytomel TABLET
Marketing CategoryNDA
Application NumberNDA010379
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1956-05-08

Drug Details

Active Ingredients

IngredientStrength
LIOTHYRONINE SODIUM50 ug/1

OpenFDA Data

SPL SET ID:51452b31-ff68-4e0c-b982-c15502ebf1d3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 903699
  • 903697
  • 903458
  • 903456
  • 903705
  • 903703

    • Pharmacological Class

    • l-Triiodothyronine [EPC]
    • Triiodothyronine [CS]

    Medicade Reported Pricing

    60793011701 CYTOMEL 50 MCG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Cytomel" or generic name "Liothyronine Sodium"

    NDCBrand NameGeneric Name
    50090-0413Cytomelliothyronine sodium
    60793-116CytomelCytomel
    60793-115CytomelCytomel
    60793-117CytomelCytomel
    43742-0956LiothyronineLiothyronine Sodium
    0093-2178Liothyronine SodiumLiothyronine Sodium
    0093-2179Liothyronine SodiumLiothyronine Sodium
    0093-2180Liothyronine SodiumLiothyronine Sodium
    0179-0238Liothyronine SodiumLiothyronine Sodium
    0574-0220Liothyronine SodiumLiothyronine Sodium
    0574-0222Liothyronine SodiumLiothyronine Sodium
    0574-0223Liothyronine SodiumLiothyronine Sodium
    16714-166Liothyronine sodiumLiothyronine sodium
    16714-167Liothyronine sodiumLiothyronine sodium
    16714-168Liothyronine sodiumLiothyronine sodium
    33261-964Liothyronine SodiumLiothyronine Sodium
    39822-0151Liothyronine SodiumLiothyronine Sodium
    42291-417Liothyronine SodiumLiothyronine Sodium
    42291-418Liothyronine SodiumLiothyronine Sodium
    42291-419Liothyronine SodiumLiothyronine Sodium
    42794-018Liothyronine SodiumLiothyronine Sodium
    42794-019Liothyronine SodiumLiothyronine Sodium
    42794-020Liothyronine SodiumLiothyronine Sodium
    43063-252Liothyronine SodiumLiothyronine Sodium
    43063-253Liothyronine SodiumLiothyronine Sodium
    43063-884Liothyronine SodiumLiothyronine Sodium
    50090-3131Liothyronine SodiumLiothyronine Sodium
    50090-5586Liothyronine sodiumLiothyronine sodium
    42023-120Triostatliothyronine sodium

    Trademark Results [Cytomel]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CYTOMEL
    CYTOMEL
    75274531 2167335 Live/Registered
    KING PHARMACEUTICALS RESEARCH AND DEVELO
    1997-04-14
    CYTOMEL
    CYTOMEL
    71698555 0637941 Dead/Expired
    SMITH KLINE & FRENCH LABORATORIES
    1955-11-18
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.